 
        Effect of PRGF application on donor-site healing following BPTB ACL reconstruction
 
                                                    Effect of PRGF application on donor-site healing following BPTB ACL reconstruction
Healing of donor site in bone-tendon-bone ACL reconstruction accelerated with plasma rich in growth factors: a randomized clinical trial
Knee Surg Sports Traumatol Arthrosc. 2015 Apr;23(4):991-7Synopsis
43 patients undergoing anterior cruciate ligament (ACL) reconstruction with a bone-patellar tendon-bone autograft were randomized to have the surgery completed with or without the application of plasma rich growth factors (PRGF) at the donor-site following skin closure. The purpose of this study was to compare rate of donor-site repair with and without PRGF application, assessed using ultrasonogra...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.